-
Mashup Score: 1Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records - 6 month(s) ago
Objectives To assess the effectiveness of live zoster vaccine during more than 10 years after vaccination; and to describe methods for ascertaining vaccine effectiveness in the context of waning. Design Real world cohort study using electronic health records. Setting Kaiser Permanente Northern California, an integrated healthcare delivery system in the US, 1 January 2007 to 31 December 2018. Population More than 1.5 million people aged 50 years and older followed for almost 9.4 million person years. Main outcome measure Vaccine effectiveness in preventing herpes zoster, postherpetic neuralgia, herpes zoster ophthalmicus, and admission to hospital for herpes zoster was assessed. Change in vaccine effectiveness by time since vaccination was examined using Cox regression with a calendar timeline. Time varying indicators were specified for each interval of time since vaccination (30 days to less than one year, one to less than two years, etc) and adjusted for covariates. Results Of 1 505 6
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records - 6 month(s) ago
Objectives To assess the effectiveness of live zoster vaccine during more than 10 years after vaccination; and to describe methods for ascertaining vaccine effectiveness in the context of waning. Design Real world cohort study using electronic health records. Setting Kaiser Permanente Northern California, an integrated healthcare delivery system in the US, 1 January 2007 to 31 December 2018. Population More than 1.5 million people aged 50 years and older followed for almost 9.4 million person years. Main outcome measure Vaccine effectiveness in preventing herpes zoster, postherpetic neuralgia, herpes zoster ophthalmicus, and admission to hospital for herpes zoster was assessed. Change in vaccine effectiveness by time since vaccination was examined using Cox regression with a calendar timeline. Time varying indicators were specified for each interval of time since vaccination (30 days to less than one year, one to less than two years, etc) and adjusted for covariates. Results Of 1 505 6
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 8JCI Insight - Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine - 7 month(s) ago
ResearchIn-Press PreviewCOVID-19Immunology Open Access | 10.1172/jci.insight.172510 Thomas Cleven,1 Hailey Bussan,1 Boyd L. Yount Jr.,2 Ryuta Uraki,3 Kiyoko Iwatsuki-Horimoto,3 Michiko Koga,4 Shinya Yamamoto,4 Hiroshi Yotsuyanagi,4 Hongtae Park,1 Jay S. Mishra,5 Sathish Kumar,5 Ralph Baric,2…
Source: insight.jci.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 14Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence | mBio - 7 month(s) ago
Vaccines to curb the global spread of multidrug-resistant gonorrhea are urgently needed. Here, 26 vaccine candidates identified by an artificial intelligence-driven platform (Efficacy Discriminative Educated Network[EDEN]) were screened for efficacy in …
Source: journals.asm.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 33Review estimates 69% 3-dose vaccine efficacy against long COVID - 7 month(s) ago
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A meta-analysis today in Antimicrobial Stewardship & Healthcare Epidemiology estimates a vaccine effectiveness (VE) of 69% for three doses of COVID-19 vaccine against long COVID, while two doses offer 37% efficacy. Led by researchers at the University of Iowa, the meta-analysis involved 24 studies on COVID-19 VE against long COVID among recipients of at least two doses of a vaccine before or after infection from December 2019 to June 2023.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 49COVID-19 Vaccination - 7 month(s) ago
COVID-19 vaccines protect against COVID-19. Get safety info and more.
Source: www.cdc.govCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 129Vaccines.gov - Find COVID‑19 vaccine locations near you - 7 month(s) ago
Vaccines.gov helps you find clinics, pharmacies, and other locations that offer COVID‑19 vaccines in the United States.
Source: www.vaccines.govCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
This symposium is not sponsored, endorsed or accredited by the American Academy of Pediatrics. Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™….
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 38stats - 7 month(s) ago
Learn 5 things you should know about COVID-19 vaccines.
Source: www.cdc.govCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
A company that Pfizer blamed for problems with a clinical trial testing a Lyme vaccine claims regulators gave its procedures a clean bill of health during a recent inspection.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
New study examines long term effectiveness of live shingles #vaccine @bmj_latest https://t.co/WHI2XgLgfU https://t.co/1cRc875Fu5